BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 12397360)

  • 1. Direct observation of ligand recognition by T cells.
    Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
    Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
    Maroto R; Shen X; König R
    J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.
    Krogsgaard M; Li QJ; Sumen C; Huppa JB; Huse M; Davis MM
    Nature; 2005 Mar; 434(7030):238-43. PubMed ID: 15724150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes.
    Stefanová I; Dorfman JR; Germain RN
    Nature; 2002 Nov; 420(6914):429-34. PubMed ID: 12459785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
    Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
    Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
    Gombos I; Detre C; Vámosi G; Matkó J
    Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation to naive CD4 T cells in the lymph node.
    Itano AA; Jenkins MK
    Nat Immunol; 2003 Aug; 4(8):733-9. PubMed ID: 12888794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responses.
    Schjetne KW; Gundersen HT; Iversen JG; Thompson KM; Bogen B
    Eur J Immunol; 2003 Nov; 33(11):3101-8. PubMed ID: 14579278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules.
    Weber DA; Terrell NK; Zhang Y; Strindberg G; Martin J; Rudensky A; Braunstein NS
    J Immunol; 1995 May; 154(10):5153-64. PubMed ID: 7730621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.
    Rogers PR; Grey HM; Croft M
    J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immunological synapse by membrane-bound and soluble ligands.
    González PA; Carreño LJ; Figueroa CA; Kalergis AM
    Cytokine Growth Factor Rev; 2007; 18(1-2):19-31. PubMed ID: 17344089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
    Jensen PE
    Biopolymers; 1997; 43(4):303-22. PubMed ID: 9316394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-six views of T-cell recognition.
    Krummel M; Wülfing C; Sumen C; Davis MM
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1071-6. PubMed ID: 11186308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.